BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Chapter

Reset

Active filters

Chemical substance: Risperidone

Presentation	Product	Chemical substance	Chapter	Items dispensed
Risperdal 6mg tablets 040201030BBAFAF	Risperdal	Risperidone	Central Nervous System	18
Okedi 75mg inj pre-filled syringes 0402020AABCAAAD	Okedi	Risperidone	Central Nervous System	6
Risperidone 125micrograms/5ml oral solution 040201030AAARAR	Risperidone (Systemic)	Risperidone	Central Nervous System	5
Okedi 100mg inj pre-filled syringes 0402020AABCABAE	Okedi	Risperidone	Central Nervous System	2
Risperidone 100mg prolonged-release inj pre-filled syringes 0402020AAAAAEAE	Risperidone (Parenteral)	Risperidone	Central Nervous System	2
Risperidone 75mg prolonged-release inj pre-filled syringes 0402020AAAAADAD	Risperidone (Parenteral)	Risperidone	Central Nervous System	2
Risperidone 250micrograms/5ml oral suspension 040201030AAASAS	Risperidone (Systemic)	Risperidone	Central Nervous System	1
Risperdal Quicklet 1mg orodispersible tablets 040201030BBAHAL	Risperdal	Risperidone	Central Nervous System	No data available
Risperdal Quicklet 2mg orodispersible tablets 040201030BBAIAM	Risperdal	Risperidone	Central Nervous System	No data available
Risperdal Quicklet 3mg orodispersible tablets 040201030BBAKAP	Risperdal	Risperidone	Central Nervous System	No data available
Risperdal Quicklet 4mg orodispersible tablets 040201030BBALAQ	Risperdal	Risperidone	Central Nervous System	No data available
Risperdal Quicklet 500microgram orodispersible tablets 040201030BBAJAN	Risperdal	Risperidone	Central Nervous System	No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.